CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1834.0598.4 (+5.67 %)
PREV CLOSE () 1735.65
OPEN PRICE () 1757.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6025
TODAY'S LOW / HIGH ()1751.95 1997.95
52 WK LOW / HIGH ()1250.95 2347.7
NSE1831.4091.2 (+5.24 %)
PREV CLOSE() 1740.20
OPEN PRICE () 1745.50
BID PRICE (QTY) 1831.40 (1000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 187800
TODAY'S LOW / HIGH() 1732.90 1990.00
52 WK LOW / HIGH ()1239.3 2350
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1987

Management Info :

Bhupendra Gandhi - Chairman Rajiv Gandhi - Managing Director

Registered Office :

Address : Meda Adraj , Kadi, , ,
Mehsana,
Gujarat-384441

Phone : 079 – 26445106

Email : mail@hester.in

Website : www.hester.in

Registrar's Details : MUFG Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE
NEWS
08Apr Hester Biosciences informs about compl
Hester Biosciences has informed that the details of securities demateria..
11Mar Hester Biosciences gets nod to divest
Hester Biosciences has received approval for the divestment of 43.81% eq..
11Mar Hester Biosciences informs about outco
Hester Biosciences has informed that the Board of Directors at the meeti..
05Feb Hester Biosciences informs about board
Hester Biosciences has informed that it submitted a newspaper clipping o..
02Feb Hester Biosciences informs about confe
Hester Biosciences has informed that it enclosed the transcript of the e..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit263.84521
Gross Profit 348.7 696.82
Operating Profit 356.44801.07
Net Sales 937.132921.36
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27934.60 (1.52%)
M.Cap ( in Cr)
59359.08
Pfizer (BSE)
 4939.05 (5.36%)
M.Cap ( in Cr)
22595.03
Astrazeneca Pharma I (BSE)
 8488.45 (1.66%)
M.Cap ( in Cr)
21221.13
Senores Pharmaceutic (BSE)
 1052.35 (10.22%)
M.Cap ( in Cr)
4846.45
NGL Fine-Chem (BSE)
 2346.75 (3.90%)
M.Cap ( in Cr)
1449.83
Shareholding Pattern
PROMOTERS 53.73%
NON-INSTITUTION 45.89%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75237.99-160.73 (-0.21%)
NIFTY23643.50-46.10 (-0.19%)
Dow Jones 50063.46370.26 (0.75%)
Nasdaq 26635.22232.88 (0.88%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI